Qi Gui
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
Papers in
-
- Circular RNAs in diseases 4
- RNA modifications and cancer 2
- Surgery 7
- Co-authors
- Yanbing Shen (1 shared paper)Jing Zhang (1 shared paper)Minghui Li (1 shared paper)Hui Zhang (1 shared paper)Shiying Yu (3 shared papers)Ping Peng (3 shared papers)Liang Zhuang (4 shared papers)Shu Xia (4 shared papers)
- Journals
- Medicine (3 papers)Journal of Virology (2 papers)Virology Journal (1 paper)Cell Reports (1 paper)Science Advances (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Qi Gui
27 papers receiving 311 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 109
- Molecular Biology 178
- Oncology 65
- Internal Medicine 6
- Anesthesiology and Pain Medicine 8
Countries citing papers authored by Qi Gui
This map shows the geographic impact of Qi Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Gui more than expected).
Fields of papers citing papers by Qi Gui
This network shows the impact of papers produced by Qi Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Gui. The network helps show where Qi Gui may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi Gui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 49 | |
| 2 | 2015 | 30 | |
| 3 | 2011 | 30 | |
| 4 | 2013 | 26 | |
| 5 | 2012 | 19 | |
| 6 | 2020 | 19 | |
| 7 | 2013 | 17 | |
| 8 | In vitro cytotoxic and antiproliferative effects of portulaca oleracea methanol extract on breast, cervical, colon and nasopharyngeal cancerous cell lines | 2013 | 17 |
| 9 | 2021 | 16 | |
| 10 | 2015 | 14 | |
| 11 | 2021 | 13 | |
| 12 | 2023 | 10 | |
| 13 | 2021 | 9 | |
| 14 | 2022 | 7 | |
| 15 | 2018 | 7 | |
| 16 | Increased expression of lncRNA ZEB1-AS1 in non-small cell lung cancer is associated with poor prognosis. | 2018 | 6 |
| 17 | 2023 | 4 | |
| 18 | 2017 | 4 | |
| 19 | 2020 | 4 | |
| 20 | 2015 | 3 |
About Qi Gui
Qi Gui is a scholar working on Molecular Biology, Surgery, Oncology, Cancer Research and Infectious Diseases, having authored 32 papers that have together received 314 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Pain Mechanisms and Treatments (3 papers), Cancer-related molecular mechanisms research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Treatment and Pharmacology (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (109 citations), Molecular Biology (178 citations), Oncology (65 citations), Internal Medicine (6 citations) and Anesthesiology and Pain Medicine (8 citations). Qi Gui has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Yanbing Shen, Jing Zhang, Minghui Li, Hui Zhang, Shiying Yu, Ping Peng, Liang Zhuang, Shu Xia, Chengcheng Xu and Wenshu Chen. Their work appears in journals such as Medicine, Journal of Virology, Virology Journal, Cell Reports and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.